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Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that
often persists into adulthood. ADHD and related personality traits, such as impulsivity
and callousness, are caused by genetic and environmental factors and their interplay.
Epigenetic modifications of DNA, including methylation, are thought to mediate between
such factors and behavior and may behave as biomarkers for disorders. Here, we set out
to study DNA methylation in persistent ADHD and related traits. We performed
epigenome-wide association studies (EWASs) on peripheral whole blood from
participants in the NeuroIMAGE study (age range 12–23 years). We compared
participants with persistent ADHD (n = 35) with healthy controls (n = 19) and
with participants with remittent ADHD (n = 19). Additionally, we performed EWASs of
impulsive and callous traits derived from the Conners Parent Rating Scale and the Callous-
Unemotional Inventory, respectively, across all participants. For every EWAS, the linear
regression model analyzed included covariates for age, sex, smoking scores, and
surrogate variables reflecting blood cell type composition and genetic background. We
observed no epigenome-wide significant differences in single CpG site methylation
between participants with persistent ADHD and healthy controls or participants with
remittent ADHD. However, epigenome-wide analysis of differentially methylated regions
provided significant findings showing that hypermethylated regions in the APOB andJanuary 2020 | Volume 11 | Article 161
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Frontiers in Genetics | www.frontiersin.orgLPAR5 genes were associated with ADHD persistence compared to ADHD remittance
(p = 1.68 * 10−24 and p = 9.06 * 10−7, respectively); both genes are involved in cholesterol
signaling. Both findings appeared to be linked to genetic variation in cis. We found neither
significant epigenome-wide single CpG sites nor regions associated with impulsive and
callous traits; the top-hits from these analyses were annotated to genes involved in
neurotransmitter release and the regulation of the biological clock. No link to genetic
variation was observed for these findings, which thus might reflect environmental
influences. In conclusion, in this pilot study with a small sample size, we observed
several DNA-methylation–disorder/trait associations of potential significance for ADHD
and the related behavioral traits. Although we do not wish to draw conclusions before
replication in larger, independent samples, cholesterol signaling and metabolism may be
of relevance for the onset and/or persistence of ADHD.Keywords: persistent attention-deficit/hyperactivity disorder, remittent attention-deficit/hyperactivity disorder,
callous traits, impulsivity, DNA methylation, epigenome-wide association studyINTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is a
neurodevelopmental disorder with a prevalence of 5% in
children (Polanczyk and Rohde, 2007). Of these children, 65%
show persistent symptoms of inattention and/or hyperactivity
and impulsivity during adulthood (Faraone et al., 2015), but it
remains unknown, why some patients show remittance and
others persistence of the disorder. Based on twin studies, the
heritability of the disorder has been estimated to be ~74%
(Faraone and Larsson, 2019), and a recent genome-wide
association study assessed the narrow-sense heritability based
on common genetic variants to be ~22% (Demontis et al., 2019).
Several studies have also indicated the importance of the
environment in the development of ADHD, such as prenatal
maternal stress, prenatal exposure to toxins, low birth weight
(Sciberras et al., 2017), and postnatal stress (Roskam et al., 2014).
One of the core symptoms of ADHD is an increased level of
the behavioral trait impulsivity. Another trait associated with
ADHD (Fowler et al., 2009), callousness, is predictive of offensive
and aggressive behavior (Watson and Clark, 2019; Docherty
et al., 2019). Both traits are normally distributed in the general
population (Chamorro et al., 2012; Georgiev et al., 2013), and the
extreme ends of their spectra are marked as maladaptive and
pathological (McLennan, 2016). Both genes (Brikell et al., 2018;
Moore et al., 2019) and the environment (Gescher et al., 2018;
Waller et al., 2018) play important roles in the etiology of
impulsive and callous traits.
Environmental adversities may act on behavior through
epigenetic mechanisms (Kubota et al., 2012). Epigenetic
mechanisms control gene expression downstream of both
environmental and genetic (risk) factors; for example, the
methylation of DNA at CpG sites can change in response to
an environmental stimulus (Kubota et al., 2012), which can then
influence the expression levels of genes, and some differentially
methylated genes linked to impulsive and callous behaviors and
related disorders like ADHD have recently been described2(Waltes et al., 2016; Hamza et al., 2017; Gescher et al., 2018).
Since environmental factors can play a role in the onset of
ADHD and associated symptoms (Thapar and Cooper, 2016),
it is to be expected that DNAmethylation differs between healthy
controls and people with ADHD (symptoms), which might
influence the transcription of genes regulating behavior, as
summarized by Palumbo and coworkers for aggressive
behavior (Palumbo et al., 2018).
Targeted DNA methylation studies, mostly performed in
children, reported on genes in the dopaminergic, adrenergic,
and serotonergic system associated with ADHD (Hamza et al.,
2017; Dall'Aglio et al., 2018). Only few epigenome-wide
association studies (EWAS) of ADHD and ADHD symptoms
in the general population have been performed. Such studies
were performed in children with and without ADHD (age 7–12
years) (Wilmot et al., 2016), for symptom trajectories in a general
population cohort (at birth, age 7, and 7–15 years) (Walton et al.,
2017), as well as for an adult cohort of individuals from the
general population (age 18–38 years) (van Dongen et al., 2019).
Given the fact that a percentage of children with ADHD show
remission of the disorder (Biederman et al., 2010), it may be of
relevance to study DNAmethylation patterns related to the onset
of ADHD as well as with its persistence. Up to now, no EWAS
investigated the clinical persistence of ADHD into adulthood,
representing a lack of hypothesis-generating studies of potential
epigenetics-related molecular mechanisms of persistence/
remittance of ADHD. Similar to the situation for ADHD, only
few previous EWASs investigated the association of DNA
methylation and impulsive and aggressive traits, and those
involved general population samples, only (van Dongen et al.,
2015; Cecil et al., 2018; Montalvo-Ortiz et al., 2018).
In the current pilot study, we aimed to identify methylation
differences linked to ADHD persistence, impulsivity, and
callousness in the NeuroIMAGE cohort (von Rhein et al., 2015).
We hypothesized to find DNA methylation differences between
healthy controls and participants with persistent ADHD, whereas
participants with remittent ADHD are expected to form anJanuary 2020 | Volume 11 | Article 16
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investigating the epigenome of participants with persistent and
remittent ADHD. The two behavioral traits we studied are known
to be present as continuous traits in the general population and are
closely linked to ADHD, but had not directly been selected for in
participants of the NeuroIMAGE cohort, enabling us to perform
quantitative trait analysis in the mixed population of healthy and
affected individuals in the NeuroIMAGE cohort.METHODS
Cohort
A subset of 72 independent individuals (persistent ADHD n =
35, remittent ADHD n = 18, healthy control n = 19) were
selected based on ADHD symptoms (i.e. sampling groups to
cover the extremes of the distribution) from the longitudinal
NeuroIMAGE cohort (official cohort n = 751 children with
ADHD and n = 318 healthy controls) (Cecil et al., 2018).
Participants with remittent ADHD were the scarest group
among the three and those were selected first. We included all
remitters with complete data availability and DNA isolation
from blood. However, inclusion was restricted to one remitter
per family. We then matched participants with persistent ADHD
and healthy controls to the remitters in terms of age, sex, IQ, and
perceived stress using the R package MatchIt v2.4 until reaching
the number of 72, excluding family members. Inclusion criteria
were European Caucasian descent, IQ > 70, and absence of a
diagnosis of autism, epilepsy, general learning difficulties, and
known genetic disorders. Participants with a current major
depression were excluded. Patients and controls were recruited
between 2003 and 2006 (Supplementary Table 1). In 2008–
2009, participants were re-assessed by telephone interviews, with
the same diagnostic criteria where similar loss-of-follow up rates
were observed for control (20%) and ADHD (21%) families.
Between 2009 and 2012, participants were re-assessed again.
During this third assessment, the blood samples for our
epigenetics study were taken from the participants. All
participants gave written informed consent, and the study was
approved by the regional ethics committee (Centrale Commissie
Mensgebonden Onderzoek: CMO Regio Arnhem Nijmegen;
2008/163; ABR: NL23894.091.08).
Assessment of ADHD, Impulsivity, and
Callous Traits
ADHD diagnosis was made in accordance with the DSM-IV
(Association, 2000) based on the Dutch version of the Parental
Account of Children's symptoms (PACS) at baseline (Taylor,
1991) and based on the Schedule for Affective Disorders and
Schizophrenia for children (K-SADS) during the first and second
follow up, administered to both parents and children to combine
information for diagnosis from multiple sources (Kaufman et al.,
1997). Participants who were diagnosed with ADHD had ≥6
hyperactive/impulsive and/or inattentive symptoms, met the
DSM-IV criteria for pervasiveness and impairment (measures
derived from the K-SADS), and showed an age of onset before 12Frontiers in Genetics | www.frontiersin.org 3years. The presence of any other psychiatric disorder was
assessed with a procedure similar to the ADHD interview
(combination of K-SADS and CPRS).
The scores derived from the PACS and K-SADS were
combined with the Conners Teacher Rating Scale: Long
version for children <18 years (Conners et al., 1998a) and the
Conners Adult ADHD Rating Scale-Self Report: Long version for
participants ≥18 years (Conners et al., 1997), depending on the
age of the participant (cut-off 18 years). Participants originally
diagnosed with ADHD, but not meeting the ADHD diagnostic
criteria at follow-up anymore, were classified as remitters
(Francx et al., 2015). We did not include participants in our
analysis that developed late-onset ADHD. All questionnaires
were administered by well-trained research-assistants.
Additional information about the diagnostic criteria can be
found in the publication of von Rhein and coworker (von
Rhein et al., 2015).
To measure impulsivity, the raw scores of the Global restless–
impulsive scale I of the Conners Parent Rating Scale (CPRS) were
used (Conners et al., 1998b). In total, seven items were scored
with either 0 or 1 point: restless or overactive; irritable or
impulsive; does not finish the things he/she starts with; has
sloppy handwriting; cannot sit still or is wobbling nervously;
disturbs other children; and wants desires to be met immediately.
Total scores of the Global restless–impulsive scale I of the CPRS
can be found in Table 1 and Supplementary Figure 1.
To measure callous traits, participants completed the
Inventory of Callous-Unemotional Traits (Kimonis et al.,
2008). We created a combined score for callousness by
selecting the following nine items reflecting callous behavior:
What I think is right and wrong is different from what other
people think; I do not care whom I hurt to get what I want; I feel
bad or guilty when I do something wrong*; I am concerned about
the feelings of others*; I apologize to persons I hurt*; I try not to
hurt others' feelings*; I do not feel remorseful when I do
something wrong; The feelings of others are unimportant to
me; and I do things to make others feel good*. Questions with an
* indicate inverse questions, meaning that scores were inverted to
calculate callous scores. Questions were scored on a scale of 0–3
(0 = not at all true, 1 = somewhat true, 2 = very true, 3 =
definitely true). The final score for a subject could range between
0 and 27. The combined score we created reflects a continuous
callous trait, which showed a wider distribution in the selected
population than the unemotional component of the behavior, as
it also includes offensive behavior.DNA Methylation Profiling
DNA was isolated from peripheral blood at the department of
Human Genetics of the Radboud University Medical Center in
Nijmegen using standard protocols, and an epigenome-wide
analysis was performed with the Infinium® MethylationEPIC
BeadChip (Illumina, San Diego, USA) by Life & Brain GmbH,
Bonn, Germany. The readEPIC() function of the wateRmelon
package was used to import methylation data and to compare
intensities of methylated (M) and unmethylated (U) DNA
(Pidsley et al., 2013). Bisulphite conversion rates wereJanuary 2020 | Volume 11 | Article 16
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Correlation between 59 common SNPs was used to identify
duplicate samples. No probes were excluded based on bisulfite
conversion rates or sample duplicates. All probes with bead count
<3 in >5% of the samples (n = 9,735) or >1% of samples with a
detection p-value >0.05 (n = 4,126) were removed. Beta-values
(methylated/unmethylated) were calculated for all probes and were
matched to the probe annotation of the EPIC array v1.0 B4
(Illumina Inc., 2017, San Diego, USA) to be used for subsequent
analysis. Probes known to cross-hybridize with each other were
removed, as were CpG sites with a minor allele frequency <0.05, to
be sure effects are because of differentially methylation rather than
genomic variation at a CpG site (McCartney et al., 2016). Probes on
the X-chromosome that passed quality control were used to verify
sex in all participants, by multidimensional scaling (MDS, n
components = 2). With the DNA Methylation Age Calculator
(https://dnamage.genetics.ucla.edu/home) the age of the subjects at
the time of sampling was calculated (Horvath, 2013). Of the
866,554 probes on the array, 853,539 CpG sites passed all QC steps.Assessment of Smoking as Covariate
Since smoking is known to affect DNA methylation (Zeilinger
et al., 2013), and participants with ADHD indicated to be
smokers more often than healthy controls, we corrected for
smoking in our model. A smoking score was calculated per
individual, based on 177 CpG sites currently known to be
differentially methylated by smoking (Zeilinger et al., 2013; Li
et al., 2018). The average methylation effect of these CpG sites
was calculated based on a discovery and replication cohort as
previously described by Elliot and co-workers (Elliott et al.,
2014). These smoking scores were used as covariate in the
statistical model to account for an individual's smoking status
instead of the self-reported smoking status, since this score
incorporates past smoking, which was not available at
sufficient depth from questionnaires.Frontiers in Genetics | www.frontiersin.org 4Surrogate variable (SV) analysis is a method to capture
heterogeneity across the data not caused by the variables of
interest and is sensitive enough to detect possible differences of
blood cell composition (SV 1 showed a Pearson's correlation =
0.9 with the most abundant blood cell type), ethnical descent,
and chip position (Leek and Storey, 2007; Kaushal et al., 2017).
SVs were created via the “sva” package in R (Leek et al., 2012),
and all 10 SVs from the model were included as covariates in the
statistical model.
Statistical Analysis
All analyses were performed in R 3.4.4. Differences in
demographics were tested with a one-way-ANOVA. Methylation
differences at the single CpG site level were analyzed by means of a
linear model with sex, age, smoking score, and 10 SVs as covariates,
since sex, age, and smoking are known to affect DNA methylation
(Zeilinger et al., 2013; van Dongen et al., 2016). We did not include
stimulant medication as a covariate, since there is no evidence that
it affects DNA methylation (Wilmot et al., 2016). To prevent
overcorrection of the model by including additional covariates of
unknown relevance, we included the 10 SVs. We ran the following
comparisons: (1) healthy controls (n = 19) and participants with
persistent ADHD (n = 35), (2) participants with remittent ADHD
(n = 18) and with persistent ADHD. Two additional EWASs were
performed for impulsive and callous traits as continuous measures.
The study-wide epigenome-wide significant p-value threshold was
set at p < 9 * 10−8 (Mansell et al., 2019). However, given the
exploratory character of our study, we also considered nominally
significant results with p < 5 * 10−5, unadjusted for the number of
EWASs performed. Inflation factors for the regression model were
calculated as the square root of the expected median of a chi-
squared statistics distribution divided by the median of the chi-
statistics with one degree of freedom.
The “Comb-p” Python module was used to identify
differentially methylated regions (DMR) in all analyses
(Pedersen et al., 2012). A region was considered to be a DMRJanuary 2020 | Volume 11 | Article 16TABLE 1 | Characteristics of samples included in the NeuroIMAGE DNA methylation study.
Healthy control Remittent ADHD Persistent ADHD Total/
average
P-value
(one-way ANOVA)
N 19 18 35 71
% Male 68 67 77 73 0.6683
Age
Mean (SD)
20.12 (2.83) 21.69 (3.38) 20.93 (2.64) 20.91
(2.90)
0.2622
IQ
Mean (SD)
113.83 (10.35) 101.17 (16.11) 96.06 (17.56) 101.94 (16.95) 0.0003*
control differs from remittent (4.22) and persistent
(6.06)
DNA methylation smoking
score
5.39 (2.01) 5.82 (2.79) 6.54 (2.64) 6.05 (2.56) 0.2635
Impulsivity 1.294 (1.49) 7.611 (5.94) 9.914 (5.43) 7.229 (6.02) <0.0001*
control differs from remittent (5.34) and persistent
(8.34)
Callous 7.00 (2.22) 9.389 (4.70) 11.086 (5.31) 9.6 (4.84) 0.0114*
control differs from remittent (2.22) and persistent
(4.36)*Significant p-value (<0.05).
In the p-value (obtained with one-way-ANOVA) column, number between brackets reflect the Tukey's multiple comparison test q-value for the mentioned groups.
ADHD, attention-deficit/hyperactivity disorder; ANOVA, analysis of variance.
Meijer et al. DNA Methylation in Persistent ADHDif at least two methylation sites were differentially methylated
within a 500 bp window (Šidák-corrected p-value < 0.05)
(Crawford et al., 2018).Biological Interpretation of Top-Findings
To assess whether the observed levels of CpG methylation
depend on genetic variation, methylation quantitative trait loci
(meQTL) were assessed for all nominally significant CpG sites
from the former analyses. Databases on meQTLs in peripheral
blood during adolescence (Gaunt et al., 2016) and in the dorsal
lateral prefrontal cortex in adults (Ng et al., 2017) were used. A
SNP with <1 Mb distance to the corresponding CpG site was
considered to be a trans-meQTL. In addition, expression
quantitative trait methylations (eQTM) were assessed via the
genome browser of iMETHYL, based on experiments in
neutrophils isolated from 100 healthy Japanese subjects
(Hachiya et al., 2017).RESULTS
The characteristics of the study sample are displayed in Table 1.
There were no significant differences between healthy controls
(n = 19) and participants with remittent (n = 18) and with
persistent ADHD (n = 35) for age, sex, and smoking score (Table
1), for which the samples had been matched. Healthy controls
showed significantly higher IQ than participants with remittent
and persistent ADHD (p = 0.0003, Tukey's multiple comparison
test q = 4.22 and 6.06, respectively). Impulsivity (p < 0.0001,
Tukey's multiple comparison test q = 5.34 and 8.34) and
callousness (p = 0.0114, Tukey's multiple comparison test q =
2.22 and 4.36) scores also differed between participants with
ADHD and controls. Distributions of impulsive and callous
traits overlapped among the different groups, showing a wide
spread (Supplementary Figure 1). The continuous traits did not
correlate with each other (Pearson's r = 0.215, p = 0.073),
indicating that the analysis on impulsivity and callousness were
supplementary to each other.Robust Epigenetic Signatures of Age and
Tobacco Use Validate DNA Methylation
Data
To verify the robustness of our DNA methylation signal, we
aimed to validate reported age by measuring DNA methylation
age. The average chronological age predicted from methylation
data was 14.78 years (SD = 3.43), and this was strongly correlated
with actual age (r = 0.650, p = 6.5 * 10−10) (Supplementary
Figure 2A). Individuals with the highest deviation from reported
age were participants with ADHD and smokers. Testing markers
of smoking exposure during adulthood, we identified a
significant association between the methylation-derived
smoking scores and self-reported smoking behavior, with
current smokers having higher smoking scores compared to
non-smokers (p = 2.38 * 10−8, Supplementary Figure 2B).Frontiers in Genetics | www.frontiersin.org 5DNA Methylation Profiles of Healthy
Controls and Participants With Persistent
and Remittent ADHD Differ
To assess DNA methylation profiles associated with persistent
ADHD, we compared methylation levels of participants with
persistent ADHD with those of healthy controls, estimated by
averaging across all probes on the array included in our analyses.
The inflation factor of 0.996 showed that no inflation was present
in the model. Here, no global differences in DNA methylation
were found between participants with persistent ADHD (mean
proportion of methylated CpG sites = 0.616, SD = 0.0009) and
healthy controls (mean proportion of methylated CpG sites =
0.615, SD = 0.001, p = 0.2246). While no individual probes
passed the experiment-wide significance threshold, seven CpG
sites showed differential methylation at our more lenient,
suggestive significance threshold of p < 5 * 10−5 (Figure 1A,
Supplementary Table 2, Supplementary Figure 3A). In the
comparison between persistent and remittent ADHD, global
differences in DNA methylation did reach significance (mean
proportion of methylated CpG sites persisters = 0.616, SD
persisters = 0.0009; mean proportion of methylated CpG sites
remitters = 0.615, SD remitters = 0.0040; t-test p = 0.00115).
Comparing individual DNA methylation differences between
participants with persistent and remittent ADHD, we did not
identify any differentially methylated probes passing the
experiment-wide significance threshold. The inflation factor of
0.969 showed that no inflation-depth explanatory analysis on
nominally significn was present in the model. Five CpG sites
showed differential methylation at our more lenient, suggestive
significance threshold (p < 5 * 10−5) (Figure 1B, Supplementary
Table 2, Supplementary Figure 3B). In-depth explanatory
analysis on nominally significant sites can be found in the
Supplementary Text and corresponding tables.
In the regional analysis, we identified a small DMR in the
PPT2 gene (65 bp containing four probes) to be significantly
hypomethylated in participants with persistent ADHD
compared to healthy controls (Šidák-corrected p-value = 0.030,
Figure 1C). Two additional significant DMRs were found to be
associated with ADHD persistence in the comparison between
participants with persistent and remittent ADHD after
correct ion for mult ip le tes t ing . Both DMRs were
hypermethylated in the participants with persistent ADHD
(Figures 1D, E); one was located within 200 bp of the
transcription start site of the APOB gene, spanning 485 bp,
consisting of 10 measured CpGs (Šidák-corrected p-value = 1.66
* 10−24, Figure 1D), and one was present in the LPAR5 gene,
spanning 123 bp and containing four probes (Šidák-corrected p-
value = 9.06 * 10−7, Figure 1E). Probes in the APOB DMR had
also been found nominally associated in the single-probe analysis
(Supplementary Table 2).
Differential Methylation Observations in
Persistent ADHD Might Be Genomic
Effects
To assess whether the differential methylation observed in
persistent ADHD might be dependent on genetic variation,January 2020 | Volume 11 | Article 16
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the APOB DMR. Forty-seven SNPs were meQTLs for the third
CpG site in the LPAR5 DMR (Supplementary Table 3). This
suggests that the differences we observed between participants
with persistent and remittent ADHD might be genomic effects.
Moreover, 8.1% of the measured meQTL SNPs—more than one
would expect by chance (X = 5.008, p = 0.025)—were associated
(unadjusted p-value < 0.05) with adult, persistent ADHD in a
recent GWAS meta-analysis (Rovira et al., 2019), but none of the
findings survived correction for multiple testing.
DNA Methylation Profiles Associated With
Impulsive and Callous Traits
No epigenome-wide significant CpG sites correlated with
impulsive traits (analyzed in n = 70) (Figure 2A, Supplementary
Table 4) or callousness (Figure 2B, Supplementary Table 4). For
both analyses, no inflation was present showed by an inflationFrontiers in Genetics | www.frontiersin.org 6factor of 0.998 and 0.980, respectively. Regional analyses also did
not reveal DMRs associated with either impulsive or callous traits.DISCUSSION
In the current study, we aimed to 1) identify differences in
peripheral blood DNA methylation profiles linked to the
persistence of ADHD, and 2) find DNA methylation levels
correlated with impulsive and callous traits. To our knowledge,
this is the first study in which differences in DNA methylation
levels in participants with persistent and remittent ADHD were
investigated. This study showed global DNA methylation
differences between participants with persistent ADHD
compared to participants with remittent ADHD. Two DMRs,
in APOB and LPAR5, were found significantly differentially
methylated between participants with remittent and persistentFIGURE 1 | Differential DNA methylation in persistent attention-deficit/hyperactivity disorder (ADHD). −log10(p-values) of the methylation sites are plotted along their
chromosomal position for (A) n = 35 participants with persistent ADHD and n = 19 healthy controls and (B) n = 35 participants with persistent and n = 18
participants with remittent ADHD. The horizontal blue line indicates the nominally significance threshold of −log10(5). One differentially methylated region was found in
(C) PPT2 for participants with persistent ADHD (red) compared to healthy controls (light blue). Differentially methylated regions were found in (D) APOB and (E)
LPAR5 for participants with persistent compared to remittent ADHD (dark blue). Each circle represents a CpG site, of which DNA methylation levels are plotted for
the corresponding chromosomal location. Individual p-values per CpG sites are located next to the site, and a combined p-value is given in the upper right corner.January 2020 | Volume 11 | Article 16
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methylated between participants with persistent ADHD and
healthy controls, and participants with persistent and remittent
ADHD based on a more lenient, suggestive significance level of
p < 5 * 10−5. Lastly, we showed that impulsive and callous traits
were associated with 18 differentially methylated CpG sites at
this lenient threshold.
Global DNA Methylation Differences
Between Groups
We found that global methylation differences were lower in
participants with persistent ADHD than in healthy controls. It is
known that DNA methylation gradually decreases during aging
(Horvath and Raj, 2018), and it has been shown that DNA
methylation based on aging can be accelerated in patients with
psychiatric disorders (Han et al., 2018; Okazaki et al., 2019) and in
smokers (Zeilinger et al., 2013). This is consistent with our finding
that individuals with the largest deviation between actual and
predicted age based on DNA methylation (i.e. higher predicted
age) were the individuals with ADHD reporting to be smokers.Blood DNA Methylation Associated With
ADHD Persistence Correlated With Brain
DNA Methylation
We expected to find biomarkers of ADHD persistence and
associated traits in the DNA isolated from peripheral blood. Such
biomarkers do not necessarily reflect brain DNA methylation
status, and we have no information on any causal relationships
with disease. Some of our findings did show a relatively high
correlation with methylation levels in different brain regions. The
lack of blood–brain correlation in methylation observed for many
of our findings is not necessarily due to the limited sample size of
our study. A recent methylome-wide association study for
schizophrenia (N = 1448) found that most of their top-findings
were also specific for blood, but that half of their sites were located
in genes that were enriched in brain-specific GO-terms (Chan et al.,
2019). These findings suggest that the DNA methylation markers
we identified in blood could also be relevant for brain-related
processes and behaviors.Frontiers in Genetics | www.frontiersin.org 7Comparison With DNA Methylation Sites in
Previous (Epi)Genetic Studies
Previous studies investigating the epigenome in ADHD in a
candidate gene-based manner have reported differential
methylation in the serotonin and dopamine system (Hamza
et al., 2017), which had earlier been implicated in ADHD
through candidate gene-based genetic studies (Faraone and
Larsson, 2019). We did not find any genes related to the
dopamine and serotonin systems among our most strongly
associated DNA methylation sites for persistent ADHD. While
this does not invalidate either the findings from the epigenetic
candidate-gene studies nor ours, it may suggest that epigenetic
effects in these systems may not be those with the strongest effect
sizes. Our observed differential DNA methylation sites also did
not overlap with any of the few published EWASs for ADHD,
ADHD symptoms, or aggression (Wilmot et al., 2016; Walton
et al., 2017; van Dongen et al., 2019). The lack of reproducibility
could be explained by our low sample size, the sample
populations used (clinical, general population, or mixed
cohorts), and the different arrays used for DNA methylation
quantification (450K or 850K array).
Based on genetic, rather than epigenetic studies, we did find
support for the observed differential methylation sites associated
with ADHD. Our most significant finding hints toward fatty acid
metabolism in persistent ADHD, and genes involved in fatty acid
metabolism and fatty acid oxidation pathways have also been
indicated to be differentially methylated in participants with
ADHD compared to healthy controls (Wilmot et al., 2016;
Walton et al., 2017).
DNA Methylation in Fatty Acid Metabolism
Pathways Might Be a Marker for
Persistent ADHD
We identified both DMRs and single DNA methylation sites in
APOB and LPAR5 to be differentially methylated between
part ic ipants with persistent and remittent ADHD.
Hypermethylation of APOB in participants with persistent
ADHD compared to those with remittent ADHD implies
lower APOB expression in those with persistent ADHD, but
was not validated. APOB is the primary lipoprotein found on theFIGURE 2 | Differential DNA methylation in impulsive and callous traits. −log10(p-values) of the methylation sites for (A) impulsive traits measured by the CPRS (n =
70) and (B) callousness (n = 71). The horizontal blue line indicates our more lenient suggestive significance threshold of −log10(5).January 2020 | Volume 11 | Article 16
Meijer et al. DNA Methylation in Persistent ADHDsurface of low density lipoproteins (LDL), which transports fatty
acids and cholesterol throughout the body (Dashti et al., 2011).
As indicated above, genes involved in fatty acid metabolism and
fatty acid oxidation pathways have been indicated to be
differentially methylated in patients with ADHD compared to
healthy controls (Wilmot et al., 2016; Walton et al., 2017). This is
also in concordance with previously published literature stating
that lipid levels, specifically LDL levels, in blood are altered in
patients with ADHD (Avcil, 2018; Pinho et al., 2018), and that
LDL and APOB are the most discriminating lipid markers in
children with ADHD (Irmisch et al., 2011). Moreover, the
ADHD medication methylphenidate is known to alter blood
lipid profiles (Charach et al., 2009), and a recent GWAS of
ADHD found significant genetic correlations between ADHD
and HDL cholesterol and LDL cholesterol (Demontis et al.,
2019). A potential role of APOB in ADHD is underlined even
more by the fact that mice knocked-out for the LDL-receptor
(LDLR−/−) show hyperactivity (Elder et al., 2008). These mice
lack the receptor for the LDL particles, containing APOB.
However, it should be noted that lipoproteins functioning in
the brain are exclusively produced in the brain, and therefore,
blood and brain lipid levels might be very different from each
other within individuals (Wang and Eckel, 2014). It was
therefore important to find that blood DNA methylation levels
for APOB correlated with brain DNA methylation levels in our
analysis, suggesting similar expression regulation. APOB can be
modified with oxidized aldehyde products, resulting in oxidized
LDL (oxLDL) (Itabe et al., 2011), which can cause inflammation
(Lara-Guzman et al., 2018). Another molecule that is produced
by the oxidization process of LDL is LPA (Nsaibia et al., 2017).
This molecule promotes inflammation after binding the LPAR5
(Ramesh et al., 2018). Mice depleted with LPA5 show nocturnal
hyperactivity (Callaerts-Vegh et al., 2012), a second animal
model in the APOB-related pathway showing ADHD
symptoms. A more elaborate model of the potential role of
APOB in persistent ADHD can be found in Supplementary
Figure 4 and the Supplementary Text.
Strengths and Limitations
Our study shows several strengths and limitations. To our
knowledge, we are the first to show differential methylation
patterns in a cohort, in which we could compare participants
with persistent and remittent ADHD. Although the sample size
was small, patients and controls were carefully matched, and
therefore, in terms of demographics, our group was as
homogeneous as possible. Given the small sample size, it is
promising that we find significant DMRs in two genes. However,
all findings should be interpreted with caution, and results
should be replicated in independent, bigger cohorts.
Conclusion
We showed that hypermethylation of APOB and LPAR5 in
peripheral blood might be associated with persistence of ADHD,
which is probably due to genetic variation influencing DNA
methylation. These data, which suggest an involvement of fatty
acid metabolism, provide new hypotheses for research into the
molecular mechanism of persistent ADHD and associated traits.Frontiers in Genetics | www.frontiersin.org 8DATA AVAILABILITY STATEMENT
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